Path following method < Pathogenesis < Pathogenicity

Facettes :

List of bibliographic references indexed by Pathogenesis

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001518 (2012)	QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine]	Hypoxia regulation of ATP13A2 (PARK9) gene transcription
002401 (2008)	Frank J. S. Lee [Canada] ; FANG LIU [Canada]	Genetic factors involved in the pathogenesis of Parkinson's disease
002623 (2007)	S. Potvin [Canada] ; S. Grignon [Canada]	Dopamine et douleur : une revue de littérature : Fibromyalgie
002894 (2006)	Fannie St-Gelais [Canada] ; Claudia Jomphe [Canada] ; Louis-Eric Trudeau [Canada]	The role of neurotensin in central nervous system pathophysiology : What is the evidence?
002B14 (2005)	Shawn Hayley [Canada] ; Hymie Anisman [Canada]	Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action
002B38 (2005)	Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France]	Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats
002C96 (2004)	Alexander Zimprich [Allemagne] ; Bertram Müller-Myhsok [États-Unis] ; Matthew Farrer [États-Unis] ; Petra Leitner [Allemagne] ; Manu Sharma [Allemagne] ; Mary Hulihan [États-Unis] ; Paul Lockhart [États-Unis] ; Audrey Strongosky [États-Unis] ; Jennifer Kachergus [États-Unis] ; Donald B. Calne [Canada] ; Jon Stoessl [Canada] ; Ryan J. Uitti [États-Unis] ; Ronald F. Pfeiffer [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Nikolaus Homann [Autriche] ; Erwin Ott [Autriche] ; Karoline Wenzel [Autriche] ; Friedrich Asmus [Allemagne] ; John Hardy [Royaume-Uni] ; Zbigniew Wszolek [États-Unis] ; Thomas Gasser [Allemagne]	The PARK8 locus in autosomal dominant Parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval
002D25 (2004)	Chong S. Lee [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Lisa Kuramoto [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]	Lack of Regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
002E41 (2003)	William D. Hutchison [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano	Pallidal neuronal activity: Implications for models of dystonia
002E43 (2003)	Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]	Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002E91 (2003)	Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada]	[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease
002F06 (2003)	K. Fuxe [Suède] ; L. F. Agnati [Italie] ; K. Jacobsen [Canada] ; J. Hillion [États-Unis] ; M. Canals [Espagne] ; M. Torvinen [Suède] ; B. Tinner-Staines [Canada] ; W. Staines [Canada] ; D. Rosin [États-Unis] ; A. Terasmaa [Suède] ; P. Popoli [Italie] ; G. Leo [Italie] ; V. Vergoni [Italie] ; C. Lluis [Espagne] ; F. Ciruela [Espagne] ; R. Franco [Espagne] ; S. Ferre [États-Unis]	Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease
002F40 (2003)	A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada]	Dopamine receptors in Parkinson's disease: Imaging studies
002F50 (2003)	Stephen J. Kish [Canada]	Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
002F53 (2003)	David K. Simon [États-Unis] ; Jennifer Friedman ; Xandra O. Breakefield [États-Unis] ; Joseph Jankovic [États-Unis] ; Mitchell F. Brin [États-Unis] ; John Provias [Canada] ; Susan B. Bressman [États-Unis] ; Michael E. Charness [États-Unis] ; Daniel Tarsy [États-Unis] ; Donald R. Johns [États-Unis] ; Mark A. Tarnopolsky [Canada]	A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia
003057 (2002)	T. A. Greenwood [États-Unis] ; M. Alexander [États-Unis] ; P. E. Keck [États-Unis] ; S. Mcelroy [États-Unis] ; A. D. Sadovnick [Canada] ; R. A. Remick [Canada] ; S. H. Jr Shaw [États-Unis] ; J. R. Kelsoe [États-Unis]	Segmental linkage disequilibrium within the dopamine transporter gene
003060 (2002)	Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada]	Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases
003076 (2002)	Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]	Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
003081 (2002)	Stefan Müller-Lissner [Allemagne]	General geriatrics and gastroenterology: constipation and faecal incontinence
003103 (2002)	Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Othman Ghribi [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]	Alteration of glutamate receptors in the striatum of dyskinetic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment
003104 (2002)	J. M. Woulfe [Canada] ; R. Duke [Canada] ; J. M. Middeldorp [Pays-Bas] ; S. Stevens [Pays-Bas] ; M. Vervoort [Pays-Bas] ; M. Hashimoto [États-Unis] ; E. Masliah [États-Unis] ; P. Chan ; D. A. Di Monte [États-Unis] ; J. W. Langston [États-Unis] ; G. Petzinger [États-Unis] ; H. Hoogendoorn [Canada] ; D. G. Munoz [Canada, Espagne]	Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Pathogenesis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Pathogenesis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Pathogenesis
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022